Cargando…

MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongbin, Chai, Siyuan, Chen, Lintao, Wang, Yubizhuo, Cheng, Yongna, Fang, Quan, Wu, Guosen, Wang, Xiangming, Liang, Wenjie, Xiao, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247642/
https://www.ncbi.nlm.nih.gov/pubmed/34221954
http://dx.doi.org/10.3389/fonc.2021.611738
_version_ 1783716558685601792
author Zhang, Hongbin
Chai, Siyuan
Chen, Lintao
Wang, Yubizhuo
Cheng, Yongna
Fang, Quan
Wu, Guosen
Wang, Xiangming
Liang, Wenjie
Xiao, Wenbo
author_facet Zhang, Hongbin
Chai, Siyuan
Chen, Lintao
Wang, Yubizhuo
Cheng, Yongna
Fang, Quan
Wu, Guosen
Wang, Xiangming
Liang, Wenjie
Xiao, Wenbo
author_sort Zhang, Hongbin
collection PubMed
description INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), aiming to identify valuable features for HSC diagnosis. METHODS: In total, 17 pathologically confirmed HSC cases, 50 HCC cases and 50 common ICC cases were enrolled from two hospitals. The clinical characteristics and MRI features of all cases were summarized and statistically analyzed. RESULTS: On the one hand, the incidence rates of elevated carbohydrate antigen (CA) 19-9 and elevated carcinoembryonic antigen (CEA) were significantly higher in the HSC cases than in the HCC cases (29.4% vs. 0%; 17.6% vs. 0%). The HSC enhancement patterns, primarily including progressive enhancement, were also significantly different from HCC cases. The incidence rates of heterogeneous signals on T2-weighted imaging and during the arterial phase were significantly higher in the HSC cases than in the HCC cases (94.1% vs. 66.0%; 100.0% vs. 72.0%). The diameter of HSCs was significantly larger than that in the HCC cases (6.12 cm vs. 4.21 cm), and the incidence rates of adjacent cholangiectasis, intrahepatic metastasis and lymph node enlargement were considerably higher in the HSC cases than in the HCC cases (52.9% vs. 6.0%; 47.1% vs. 12.0%; 41.2% vs. 2.0%). On the other hand, the incidence rate of elevated CA199 was significantly lower in the HSC cases than in the ICC cases (29.4% vs. 60.0%). The incidence rates of intratumoral necrosis and pseudocapsules were significantly higher in the HSC cases than in the HCC cases (35.3% vs. 8.0%; 47.1% vs. 12.0%). However, the incidence rates of target signs were significantly lower in the HSC cases than in the HCC cases (11.8% vs. 42.0%). In addition, there was no significant difference in the enhancement patterns between HSC cases and ICC cases. CONCLUSIONS: HSCs were frequently seen in elderly men with clinical symptoms and elevated CA199 levels. The MRI features, including large size, obvious heterogeneity, hemorrhage, progressive enhancement, pseudocapsule and lymph node enlargement, contributed to the diagnosis of HSC.
format Online
Article
Text
id pubmed-8247642
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82476422021-07-02 MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Zhang, Hongbin Chai, Siyuan Chen, Lintao Wang, Yubizhuo Cheng, Yongna Fang, Quan Wu, Guosen Wang, Xiangming Liang, Wenjie Xiao, Wenbo Front Oncol Oncology INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), aiming to identify valuable features for HSC diagnosis. METHODS: In total, 17 pathologically confirmed HSC cases, 50 HCC cases and 50 common ICC cases were enrolled from two hospitals. The clinical characteristics and MRI features of all cases were summarized and statistically analyzed. RESULTS: On the one hand, the incidence rates of elevated carbohydrate antigen (CA) 19-9 and elevated carcinoembryonic antigen (CEA) were significantly higher in the HSC cases than in the HCC cases (29.4% vs. 0%; 17.6% vs. 0%). The HSC enhancement patterns, primarily including progressive enhancement, were also significantly different from HCC cases. The incidence rates of heterogeneous signals on T2-weighted imaging and during the arterial phase were significantly higher in the HSC cases than in the HCC cases (94.1% vs. 66.0%; 100.0% vs. 72.0%). The diameter of HSCs was significantly larger than that in the HCC cases (6.12 cm vs. 4.21 cm), and the incidence rates of adjacent cholangiectasis, intrahepatic metastasis and lymph node enlargement were considerably higher in the HSC cases than in the HCC cases (52.9% vs. 6.0%; 47.1% vs. 12.0%; 41.2% vs. 2.0%). On the other hand, the incidence rate of elevated CA199 was significantly lower in the HSC cases than in the ICC cases (29.4% vs. 60.0%). The incidence rates of intratumoral necrosis and pseudocapsules were significantly higher in the HSC cases than in the HCC cases (35.3% vs. 8.0%; 47.1% vs. 12.0%). However, the incidence rates of target signs were significantly lower in the HSC cases than in the HCC cases (11.8% vs. 42.0%). In addition, there was no significant difference in the enhancement patterns between HSC cases and ICC cases. CONCLUSIONS: HSCs were frequently seen in elderly men with clinical symptoms and elevated CA199 levels. The MRI features, including large size, obvious heterogeneity, hemorrhage, progressive enhancement, pseudocapsule and lymph node enlargement, contributed to the diagnosis of HSC. Frontiers Media S.A. 2021-06-17 /pmc/articles/PMC8247642/ /pubmed/34221954 http://dx.doi.org/10.3389/fonc.2021.611738 Text en Copyright © 2021 Zhang, Chai, Chen, Wang, Cheng, Fang, Wu, Wang, Liang and Xiao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Hongbin
Chai, Siyuan
Chen, Lintao
Wang, Yubizhuo
Cheng, Yongna
Fang, Quan
Wu, Guosen
Wang, Xiangming
Liang, Wenjie
Xiao, Wenbo
MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title_full MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title_fullStr MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title_full_unstemmed MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title_short MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
title_sort mri features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247642/
https://www.ncbi.nlm.nih.gov/pubmed/34221954
http://dx.doi.org/10.3389/fonc.2021.611738
work_keys_str_mv AT zhanghongbin mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT chaisiyuan mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT chenlintao mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT wangyubizhuo mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT chengyongna mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT fangquan mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT wuguosen mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT wangxiangming mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT liangwenjie mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma
AT xiaowenbo mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma